💡 Quick answer
The landmark clinical studies, treatment history and latest research for Microneedling — fact-checked and sourced.
Research & evidence
How treatment evolved
1988FDA approves topical minoxidil 2% (Rogaine, Upjohn) on Aug 17, 1988 — the first drug approved for male pattern hair loss, establishing the topical agent later combined with microneedling.
2006Plastic surgeon Desmond Fernandes formalizes percutaneous collagen induction with a drum-shaped multi-needle roller (the modern Dermaroller), creating the standardized microneedling device later repurposed for scalp use.
2013Dhurat et al. publish the first randomized trial showing weekly dermaroller microneedling added to 5% minoxidil markedly outperforms minoxidil alone in androgenetic alopecia — the pivotal proof-of-concept for combination therapy.
2024Pei et al. publish a meta-analysis of 13 RCTs (696 patients) in J Cosmet Dermatology confirming that microneedling combined with topical drug therapy significantly outperforms monotherapy for hair density.
2025Ahmed et al. (Archives of Dermatological Research) pool 12 RCTs / ~631 patients specifically comparing microneedling+minoxidil vs minoxidil alone, quantifying the combination benefit while flagging high heterogeneity and low Caucasian representation.
Key clinical studies
Dhurat et al., 20132013
Randomized, evaluator-blinded trial; 100 men with mild-moderate AGA (Norwood III vertex/IV), 12 weeks; microneedling weekly + 5% minoxidil twice daily vs 5% minoxidil alone
Mean hair count rose +91.4 hairs/cm2 in the microneedling+minoxidil group vs +22.2 in the minoxidil-only group (~4x). 82% (41/50) of the combination group reported >50% improvement vs 4.5% (2/44) with minoxidil alone. Limitation: single-center pilot, small sample, short follow-up.
International Journal of Trichology
Ahmed et al., 20252025
Systematic review & meta-analysis; 12 RCTs (11 pooled), ~631 patients (335 microneedling+minoxidil vs 315 minoxidil alone)
Combination therapy improved hair count (SMD 1.32, 95% CI 0.73-1.92; I2=88%) and hair diameter (SMD 0.34, 95% CI 0.11-0.58; I2=0%); odds of investigator-rated improvement OR ~5.0 (95% CI 2.45-10.25). Adverse events comparable. Limitations: substantial heterogeneity, most trials from Asia/Middle East/North Africa, weak randomization reporting.
Archives of Dermatological Research
Pei et al., 20242024
Systematic review & meta-analysis of 13 RCTs, 696 AGA patients; combined microneedling therapy vs single microneedling or single drug therapy
Combined microneedling therapy significantly improved hair density vs monotherapy (mean difference 13.36 hairs, 95% CI 8.55-18.16, p<0.00001) and was about twice as likely to earn physician-rated satisfaction (RR 2.03, 95% CI 1.62-2.53). Limitation: needle depth, length and treatment intervals varied widely across studies, preventing standardized-protocol subgroup analysis.
Journal of Cosmetic Dermatology
Gupta et al. (network meta-analysis), 20232023
Systematic review & Bayesian network meta-analysis of pattern hair loss trials comparing 5% minoxidil, PRP and microneedling at ~6 months
5% minoxidil plus microneedling ranked highest for hair-density improvement (SUCRA ~95.8%), above minoxidil alone (~53.9%) and microneedling alone (~27.8%), supporting the combination as a leading option at 6 months. Limitation: indirect comparisons and variable trial quality.
Skin Appendage Disorders (Karger)
Latest research: Recent (2023-2026) work has moved from proving that microneedling helps to optimizing how it is done: 2024-2025 meta-analyses suggest shallower needles (under ~1 mm) may match or beat deeper ones and push for standardized depth/frequency protocols, while early small studies pair microneedling with PRP, exosomes or other topicals as drug-delivery enhancers. Evidence quality remains the key caveat — trials are small, heterogeneous, mostly non-Caucasian, and short-term, so guideline bodies still treat microneedling as a promising adjunct rather than an established monotherapy.
Summaries reflect published, peer-reviewed research and are not medical advice. See the linked sources for details.
Explore more
Self-check →Treatments →Transplant →Women →New →Hair Loss Causes →Hair-Loss Glossary →Hair-Loss Questions & Answers →Hair-Loss Ingredient Evidence Ratings →Hair Transplant Cost by City →Research →Browse all →
Not medical advice. General education only; it does not replace diagnosis or treatment by a licensed professional. Consult a board-certified dermatologist before starting, stopping or changing any treatment.
⚠️ When to see a doctor — don’t self-treat
- Sudden patchy or circular bald spots
- Redness, scaling, pus, pain or itch (possible scarring alopecia — treat urgently)
- Broken hairs or rapid loss
- Loss with body-wide signs (weight loss, fatigue, cycle changes, acne, extra hair)
- Loss right after a new medication
- Any hair loss in a child